Effect of extracellular human immunodeficiency virus type 1 glycoprotein 120 on primary human vascular endothelial cell cultures

AIDS Research and Human Retroviruses

Volumn 15, Issue 14, 1999, Pages 1265-1277

  Huang, Ming Bo ^a   Hunter, Melissa ^a   Bond, Vincent C ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; DNA FRAGMENT; GLYCOPROTEIN GP 120;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; PRIORITY JOURNAL; RECEPTOR BINDING; VASCULAR ENDOTHELIUM; VIRUS ENVELOPE; VIRUS PARTICLE;

ANTIGENS, CD4; APOPTOSIS; BINDING, COMPETITIVE; CELLS, CULTURED; CHEMOKINES, CXC; ENDOTHELIUM, VASCULAR; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; LIGANDS; MACROPHAGE INFLAMMATORY PROTEIN-1; RANTES; RECEPTORS, CCR5; RECEPTORS, CXCR4;

EID: 0032817897     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310160     Document Type: Article

References (74)

1. Terai C, Kornbluth RS, Pauza CD, Richman DD, and Carson DA: Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 1991;87:1710-1715.
2. Laurent-Crawford AG and Hovanessian AG: The cytopathic effect of human immunodeficiency virus is independent of high levels of unintegrated viral DNA accumulated in response to superinfection of cells. J Gen Virol 1993;74:2619-2628.
3. Ameisen JC: Programmed cell death (apoptosis) and AIDS pathogenesis. AIDS Res Hum Retroviruses 1994;10(Suppl. 1):S2-5.
4. Pantaleo G and Fauci AS: Apoptosis in HIV infection. Nature Med 1995;1:118-120. [Comment]
5. Lu YY, Koga Y, Tanaka K, Sasaki M, Kimura G, and Nomoto K: Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1. J Virol 1994;68:390-399.
6. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly RP, and Finkel TH: Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 1992;176:1099-1106.
7. Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, and Kupfer A: Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes. Nature Med 1995;1:129-134. [See comments]
8. Sunila I, Vaccarezza M, Pantaleo G, Fauci AS, and Orenstein JM: gp120 is present on the plasma membrane of apoptotic CD4 cells prepared from lymph nodes of HIV-1-infected individuals: An immunoelectron microscopic study. AIDS 1997;11:27-32.
9. Boirivant M, Pica R, DeMaria R, Testi R, Pallone F, and Strober W: Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis. J Clin Invest 1996;98:2616-2622.
10. Heinkelein M, Sopper S, and Jassoy C: Contact of human immunodeficiency virus type 1-infected and uninfected CD4+ T lymphocytes is highly cytolytic for both cells. J Virol 1995;69:6925-6931.
11. Nardelli B, Gonzalez CJ, Schechter M, and Valentine FT: CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells. Proc Natl Acad Sci USA 1995;92:7312-7316.
12. Ohnimus H, Heinkelein M, and Jassoy C: Apoptotic cell death upon contact of CD4+ T lymphocytes with HIV glycoprotein-expressing cells is mediated by caspases but bypasses CD95 (Fas/Apo-1) and TNF receptor 1. J Immunol 1997;159:5246-5252.
13. Weissman D, Rabin RL, Arthos J, Rubbert A, Dybul M, Swofford R, Venkatesan S, Farber JM, and Fauci AS: Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature (London) 1997;389:981-985.
14. Chirmule N and Pahwa S: Envelope glycoproteins of human immunodeficiency virus type 1 : Profound influence on immune functions. Microbiol Rev 1996;60:386-406.
15. Borghi P, Fantuzzi L, Varano B, Gesasni S, Puddu P, Conti L, Capobianchi MR, Ameglio F, and Belardelli F: Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages. J Virol 1995;69: 1284-1287.
16. Herbein G, Mahlknecht U, Batliwalla F, Gregersen P, Pappas T, Butler J, O'Brien WA, and Verdin E: Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature (London) 1998;395:189-194. [See comments]
17. Groux H, Torpier G, Monte D, Mouton Y, Capron A, and Ameisen JC: Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992;175:331-340.
18. Gougeon ML, Laurent-Crawford AG, Hovanessiafl AG, and Montagnier L: Direct and indirect mechanisms mediating apoptosis during HIV infection: Contribution to in vivo CD4 T cell depletion. Semin Immunol 1993;5:187-194.
19. Gougeon ML and Montagnier L: Apoptosis in AIDS. Science 1993;260:1269-1270. [Published erratum appears in Science 1993; Jun 18;260(5115):1709] [see comments].
20. Gougeon ML, Colizzi V, Dalgleish A, and Montagnier L: New concepts in AIDS pathogenesis. AIDS Res Hum Retroviruses 1993;9:287-289.
21. Boirivant M, Viora M, Giordani L, Luzzati AL, Pronio AM, Montesani C, and Pugliese O: HIV-1 gp120 accelerates Fas-mediated activation-induced human lamina propria T cell apoptosis. J Clin Immunol 1998;18:39-47.
22. Lewis DE, Tang DS, Adu-Oppong A, Schober W, and Rodgers JR: Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J Immunol 1994;153:412-420.
23. Muro-Cacho CA, Pantaleo G, and Fauci AS: Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 1995;154:5555-5566.
24. Gougeon ML, Lecoeur H, Dulioust A, Enouf MG, Crouvoiser M, Goujard C, Debord T, and Montagnier L: Programmed cell death in peripheral lymphocytes from HIV-infected persons: Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol 1996;156:3509-3520.
25. Lipton SA: Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann Neurol 1993;33:227-228. [Letter; comment]
26. Diop AG, Lesort M, Esclaire F, Sindou P, Couratier P, and Hugon J: Tetrodotoxin blocks HIV coat protein (gp120) toxicity in primary neuronal cultures. Neurosci Lett 1994;165:187-190.
27. 2+, N-methyl-D-aspartate receptors, and AIDS-related neuronal injury. Int Rev Neurobiol 1994;36:1-27.
28. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Mizrachi Y, and Volsky DJ: Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: Implications for the neuropathogenesis of HIV disease. J Exp Med 1992;176:1703-1718.
29. Heyes MP, Rubinow D, Lane C, and Markey SP: Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Ann Neurol 1989;26:275-277.
30. Dreyer EB and Lipton SA: The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid. Eur J Neurosci 1995;7:2502-2507.
31. Dreyer EB, Kaiser PK, Offermann JT, and Lipton SA: HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 1990;248:364-367. [See comments]
32. Benos DJ, Hahn BH, Bubien JK, Ghosh SK, Mashburn NA, Chaikin MA, Shaw GM, and Benveniste EN: Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: Implications for AIDS dementia complex. Proc Natl Acad Sci USA 1994;91:494-498.
33. Shrikant P, Benos DJ, Tang LP, and Benveniste EN: HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. Involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways. J Immunol 1996;156:1307-1314.
34. Lafon ME, Steffan AM, Gendrault JL, Klein-Soyer C, Gloeckler-Tondre L, Royer C, and Kirn A: Interaction of human immunodeficiency virus with human macrovascular endothelial cells in vitro. AIDS Res Hum Retroviruses 1992;8:1567-1570.
35. Moses AV and Nelson JA: HIV infection of human brain capillary endothelial cells-implications for AIDS dementia. Adv Neuroimmunol 1994;4:239-247.
36. Moses AV, Bloom FE, Pauza CD, and Nelson JA: Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc Natl Acad Sci USA 1993;90:10474-10478.
37. Cenacchi G, Re MC, Preda P, Pasquinelli G, Furlini G, Apkarian RP, La Placa M, and Martinelli GN: Human immunodeficiency virus type-1 (HIV-1) infection of endothelial cells in vitro: A virological, ultrastructural and immuno-cytochemical approach. J Submicrosc Cytol Pathol 1992;24:155-161.
38. Green DF, Resnick L, and Bourgoignie JJ: HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro. Kidney Int 1992;41:956-960.
39. Steffan AM, Lafon ME, Gendrault JL, Schweitzer C, Royer C, Jaeck D, Arnaud JP, Schmitt MP, Aubertin AM, and Kirn A: Primary cultures of endothelial cells from the human liver sinusoid are permissive for human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1992;89:1582-1586.
40. Drouet L, Scrobohaci ML, Janier M, and Baudin B: Endothelial cells: Target for the HIV1 virus? Nouv Rev Fr Hematol 1990;32:103-106.
41. Sfikakis PP, Tzavara V, Sipsas N, Kosmopoulou O, Sfikakis P, and Kordossis T: Levels of the circulating cell adhesion molecule E-selectin and disease progression in HIV infection. Infection 1995;23:207-211.
42. Conaldi PG, Serra C, Dolei A, Basolo F, Falcone V, Mariani G, Speziale P, and Toniolo A: Productive HIV-1 infection of human vascular endothelial cells requires cell proliferation and is stimulated by combined treatment with interleukin-1 beta plus tumor necrosis factor-alpha. J Med Virol 1995;47:355-363.
43. Lafon ME, Gendrault JL, Royer C, Jaeck D, Kirn A, and Steffan AM: Human endothelial cells isolated from the hepatic sinusoids and the umbilica vein display a different permissiveness for HIV1. Res Virol 1993;144:99-104.
44. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, and Weiss RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (London) 1984;312:763-767.
45. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, and Paxton WA: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature (London) 1996;381:667-673. [See comments]
46. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, and Berger EA: CC CKR5: A RANTES, MIP-lalpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
47. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, and Sodroski J: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
48. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, and Doms RW: A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85: 1149-1158.
49. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, and Landau NR: Identification of a major co-receptor for primary isolates of HIV-1. Nature (London) 1996;381:661-666. [See comments]
50. Bleul CC, Farzan M, Choe H, Parolin C, dark-Lewis I, Sodroski J, and Springer TA: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature (London) 1996;382:829-833.
51. Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV-1 entry Cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-877. [See comments]
52. Feil C and Augustin HG: Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines. Biochem Biophys Res Commun 1998;247:38-45.
53. Schonbeck U, Brandt E, Petersen F, Flad HD, and Loppnow H: IL-8 specifically binds to endothelial but not to smooth muscle cells. J Immunol 1995;154:2375-2383.
54. Middleton J, Neil S, Wintle J, Clark-Lewis I, Moore H, Lam C, Auer M, Hub E, and Rot A: Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 1997;91:385-395.
55. Chappey O, Wautier MP, Boval B, and Wautier JL: Endothelial cells in culture: An experimental model for the study of vascular dysfunctions. Cell Biol Toxicol 1996;12:199-205.
56. Herrmann M, Lorenz HM, Voll R, Grunke M, Woith W, and Kalden JR: A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res 1994;22:5506-5507.
57. Slowik MR, Min W, Ardito T, Karsan A, Kashgarian M, and Pober JS: Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interleukin-1-converting enzyme-like protease-dependent and -independent pathways. Lab Invest 1997; 77:257-267.
58. Ward SG and Westwick J: Chemokines: Understanding their role in T-lymphocyte biology. Biochem J 1998;333:457-470.
59. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, and Lusso P: identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995;270:1811-1815. [See comments]
60. Jansson M, Popovic M, Karlsson A, Cocchi F, Rossi P, Albert J, and Wigzell H: Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates. Proc Natl Acad Sci USA 1996;93:15382-15387.
61. Weiss RA, Clapham PR, Weber JN, Dalgleish AG, Lasky LA, and Berman PW: Variable and conserved neutralization antigens of human immunodeficiency virus. Nature (London) 1986;324: 572-575.
62. Hwang SS, Boyle TJ, Lyerly HK, and Cullen BR: Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991;253:71-74.
63. Bjorndal A, Deng H, Jansson M, Fiore JR, Colognesi C, Karlsson A, Albert J, Scarlatti G, Littman DR, and Fenyö EM: Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 1997;71: 7478-7487.
64. Bazan HA, Alkhatib G, Broder CC, and Berger EA: Patterns of CCR5, CXCR4, and CCR3 usage by enevelope glycoproteins from human immunodeficiency virus type 1 primary isolates. J Virol 1998;72:4485-4491.
65. Ohagen A, Ghosh S, He J, Huang K, Chen Y, Yuan M, Osathanondh R, Gartner S, Shi B, Shaw G, and Gabuzda D: Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: Evidence for a role of the envelope. J Virol 1999;73:897-906. [In Process Citation] [MEDLINE record]
66. Kameoka M, Kimura T, Zheng YH, Suzuki S, Fujinaga K, Luftig RB, and Ikuta K: Protease-defective, gp120-containing human immunodeficiency virus type 1 particles induce apoptosis more efficiently than does wild-type virus or recombinant gp120 protein in healthy donor-derived peripheral blood T cells. J Clin Microbiol 1997;35:41-47.
67. Kameoka M, Kimura T, Zhong Q, Zheng YH, Luftig RB, and Ikuta K: Induction of apoptosis by protease-defective particle preparations of human immunodeficiency virus type 1 is specific to a subset of U937-derived subclones. Int Immunol 1996;8:1687-1697.
68. Kameoka M, Suzuki S, Kimura T, Fujinaga K, Auwanit W, Luftig RB, and Ikuta K: Exposure of resting peripheral blood T cells to HIV-1 particles generates CD25+ killer cells in a small subset, leading to induction of apoptosis in bystander cells. Int Immunol 1997;9:1453-1462.
69. Bragardo M, Buonfiglio D, Feito MJ, Bonissoni S, Redoglia V, Rojo JM, Ballester S, Portoles P, Garbarino G, Malavasi F, and Dianzani U: Modulation of lymphocyte interaction with endothelium and homing by HIV-1 gp120. J Immunol 1997;159: 1619-1627.
70. Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, Young SA, Mills RG, Wachsman W, and Wiley CA: Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992;42:1736-1739.
71. Gray F: Lesions of the central nervous system in the early stages of human immunodeficiency virus infection. Rev Neurol (Paris) 1997;153:629-640.
72. Wingertsmann L, Chretien F, Authier FJ, Paraire F, Durigon M, and Gray F: Central nervous system lesions in the early stages of HIV infection. Arch Anat Cytol Pathol 1997;45:106-117.
73. Gray F, Scaravilli F, Everall I, Chretien F, An S, Boche D, Adle-Biassette H, Wingertsmann L, Durigon M, Hurtrel B, Chiodi F, Bell J, and Lantos P: Neuropathology of early HIV-1 infection. Brain Pathol 1996;6:1-15.
74. Cao YZ, Valentine F, Hojvat S, Allain JP, Rubinstein P, Mirabile M, Czelusniak S, Leuther M, Baker L, and Friedman-Kien AE: Detection of HIV antigen and specific antibodies to HIV core and envelope proteins in sera of patients with HIV infection. Blood 1987;70:575-578.